12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's after-market session, several healthcare stocks showed significant movement. Etao International Co led the gainers with a 249.4% increase, while Aquestive Therapeutics experienced the largest decline among the losers at 11.4%. Taysha Gene Therapies reported Q4 earnings, contributing to a 29.36% rise in its stock. Other notable movers include Moleculin Biotech, Turnstone Biologics, and Enveric Biosciences on the gainers' side, and Trxade Health, Ontrak, and Virpax Pharmaceuticals among the losers.
March 19, 2024 | 9:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Etao International Co's stock rose dramatically by 249.4% to $0.5, with a market cap of $51.1 million.
The significant rise in Etao International Co's stock price could attract more investor attention in the short term, potentially maintaining upward momentum.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Taysha Gene Therapies' stock increased by 29.36% to $2.91 following the release of their Q4 earnings.
The positive reaction to Taysha Gene Therapies' Q4 earnings suggests investor confidence, likely leading to short-term price support.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Aquestive Therapeutics' stock declined by 11.4% to $4.73, with a market cap of $346.7 million.
The decline in Aquestive Therapeutics' stock could lead to short-term bearish sentiment among investors, potentially affecting its stock price negatively.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90